Takeda Pharmaceutical Co Ltd (TAK) stock has fallen -0.66% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives TAK stock a score of 33 out of a possible 100.
That rank is chiefly influenced by a short-term technical score of 27. TAK's rank also includes a long-term technical score of 46.
TAK has an Overall Score of 33. Find out what this means to you and get the rest of the rankings on TAK!
Takeda Pharmaceutical Co Ltd (TAK) stock has fallen -0.62% while the S&P 500 has fallen -0.07% as of 1:32 PM on Monday, Nov 13. TAK has fallen -$0.09 from the previous closing price of $13.70 on volume of 652,501 shares. Over the past year the S&P 500 has gained 11.50% while TAK has fallen -0.66%. TAK earned $0.40 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 33.83.
Click Here to get the full Stock Report for Takeda Pharmaceutical Co Ltd stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
